Drug Trial Radar · NCT07545590
A Study of Eltrekibart (LY3041658) in Healthy Participants
Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Apr 21, 2026
Primary completion
Sep 22, 2026
Study completion Sep 22, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Apr 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate how eltrekibart is absorbed by the body when it is given under the skin to healthy participants. The study will last about 17 weeks.
Conditions
- Healthy
Interventions
LY3041658Drug
Administered SC
LY3041658Drug
Administered IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (PK): Maximum Observed Drug Concentration (Cmax) of LY3041658Time frame: Predose on Day 1 up to Day 85
- PK: Area Under the Concentration Versus Time Curve From Zero to Infinity AUC(0-∞) of LY3041658Time frame: Predose on Day 1 up to Day 85
- PK: Area Under the Concentration Versus Time Curve From Time Zero to Time t, Where t is the Last Time Point With a Measurable Concentration AUC(0-tlast) of LY3041658Time frame: Predose on Day 1 up to Day 85
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Lilly Centre for Clinical Pharmacology
Singapore, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.